Skip to main content

Erratum to: Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients

Abstract

Correction to Gupta P K, Prabhakar S, Sharma S, Anand A. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. Journal of Neuroinflammation 8:47.

Correction

The authors observe that, in Table two of our study [1], crude ORs and adjusted ORs for serum VEGFA were also repeated for CSF VEGFA, however, these values for CSF VEGFA are different from serum VEGFA. Correct OR values of CSF VEGFA are given below.

Smoking: [crude OR(95% CI) = 1.7 (0.3-9.1), p = 0.4; adj OR (95% CI) = 0.6 (0.08-4.4), p = 0.6].

Alcohol consumption: [crude OR(95% CI) = 0.6 (0.1-2.2), p = 0.4; adj OR (95% CI) = 0.8 (0.1-4.4), p = 0.8].

Meat consumption: [crude OR(95% CI) = 2.2 (0.6-7.7), p = 0.2; adj OR (95% CI) = 2.1 (0.5-7.7), p = 0.2].

References

  1. 1.

    Gupta PK, Prabhakar S, Sharma S, Anand A: Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. J Neuroinflammation. 8: 47-10.1186/1742-2094-8-47.

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Akshay Anand.

Additional information

The online version of the original article can be found at 10.1186/1742-2094-8-47

Pawan K Gupta, Sudesh Prabhakar contributed equally to this work.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gupta, P.K., Prabhakar, S., Sharma, S. et al. Erratum to: Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients. J Neuroinflammation 8, 97 (2011). https://doi.org/10.1186/1742-2094-8-97

Download citation